Lv2
200 积分 2024-07-31 加入
Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series
1个月前
已完结
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis
6个月前
已完结
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
6个月前
已完结
Compromised melanocyte survival due to decreased suppression of CD4 + & CD8 + resident memory T cells by impaired TRM‐ regulatory T cells in generalized vitiligo patients
7个月前
已完结
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
7个月前
已完结
Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
9个月前
已完结
JAK Inhibitors for the Treatment of Vitiligo: Current Evidence and Emerging Therapeutic Potential
10个月前
已完结
Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib
11个月前
已完结
Acral vitiligo and lesions over joints treated with non-cultured epidermal cell suspension transplantation
11个月前
已完结
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis
11个月前
已完结
皖公网安备34019202002308
